Deutsche Bank
VERV

Deutsche Bank’s Verve Therapeutics VERV Stock Holding History

Deutsche Bank’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,180
Closed -$575K – 3739
2025
Q2 		$575K Sell
51,180
-10,473
-17% -$59.7K ﹤0.01% 2387
2025
Q1 		$282K Sell
61,653
-3,256
-5% -$21.8K ﹤0.01% 2788
2024
Q4 		$366K Buy
64,909
+23,214
+56% +$131K ﹤0.01% 2786
2024
Q3 		$202K Buy
41,695
+14,863
+55% +$86.3K ﹤0.01% 2921
2024
Q2 		$131K Sell
26,832
-4,675
-15% -$29.4K ﹤0.01% 3023
2024
Q1 		$418K Buy
31,507
+5,068
+19% +$67.2K ﹤0.01% 2440
2023
Q4 		$369K Sell
26,439
-1,266
-5% -$15.7K ﹤0.01% 2534
2023
Q3 		$367K Buy
27,705
+2,299
+9% +$37K ﹤0.01% 2369
2023
Q2 		$476K Sell
25,406
-12,651
-33% -$211K ﹤0.01% 2403
2023
Q1 		$549K Buy
38,057
+12,240
+47% +$240K ﹤0.01% 2442
2022
Q4 		$500K Buy
25,817
+5,387
+26% +$143K ﹤0.01% 2447
2022
Q3 		$702K Buy
20,430
+2,912
+17% +$92.9K ﹤0.01% 2187
2022
Q2 		$268K Sell
17,518
-3,219
-16% -$49.9K ﹤0.01% 2992
2022
Q1 		$474K Buy
20,737
+10,766
+108% +$308K ﹤0.01% 2783
2021
Q4 		$368K Buy
9,971
+510
+5% +$21.4K ﹤0.01% 3024
2021
Q3 		$444K Buy
+9,461
New +$557K ﹤0.01% 3121

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Deutsche Bank's VERV Position: Q3 2025 in Review

Deutsche Bank sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 51,180 shares — an estimated $575K sold.

Deutsche Bank first reported a position in VERV in Q3 2021 and held it in 16 quarters. The position peaked at $702K in Q3 2022. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Deutsche Bank reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 51,180 Verve Therapeutics shares in Q3 2025, an estimated $575K.
  • Deutsche Bank first reported a position in Verve Therapeutics in Q3 2021 and held it in 16 quarters.
  • Deutsche Bank's Verve Therapeutics position peaked at $702K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.